Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice

Food and Function

Volumn 4, Issue 6, 2013, Pages 950-959

  Lee, Bao Hong ^a   Hsu, Wei Hsuan ^a   Huang, Tao ^a   Chang, Yu Yin ^a   Hsu, Ya Wen ^b   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Sunway Biotechnology Company Limited   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; FRUCTOSE; NUTRITION; TRANSCRIPTION FACTORS;

ACID ACCUMULATIONS; ANTI-INFLAMMATORIES; ANTIDIABETIC AGENTS; ELEMENT-BINDING PROTEINS; HYPERINSULINEMIA; INSULIN SENSITIVITY; MONASCUS-FERMENTED PRODUCTS; THERAPEUTIC POTENTIALS;

MAMMALS;

MONASCUS; MUS;

FRUCTOSE; FUSED HETEROCYCLIC RINGS; MONASCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL; C57BL MOUSE; CHEMISTRY; DIABETES MELLITUS; DOWN REGULATION; DRUG EFFECTS; DYSLIPIDEMIAS; FEMALE; GENETICS; HUMAN; LIPOGENESIS; MALE; METABOLISM; MONASCUS; MOUSE;

ANIMALS; DIABETES MELLITUS; DOWN-REGULATION; DYSLIPIDEMIAS; FEMALE; FRUCTOSE; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; LIPOGENESIS; MALE; MICE; MICE, INBRED C57BL; MONASCUS; PLANT EXTRACTS; PPAR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84878701755     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c3fo60062a     Document Type: Article

References (44)

1. A. T. Cheung J. Wang D. Ree J. L. Koll M. Bryer-Ash Tumor necrosis factor-α induces hepatic insulin resistance in obese zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase Diabetes 2000 49 810 819
2. A. A. Bulhak C. Jung C. C. Ostenson J. O. Lundberg P. O. Sioquist J. Pernow PPAR-α activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-kinas/Akt and NO pathway Am. J. Physiol.: Heart Circ. Physiol. 2009 296 719 727
3. W. Chanput J. Mes R. A. M. Vreeburg H. F. J. Savelkoul H. J. Wichers Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds Food Funct. 2010 1 254 261
4. I. Choi Y. Park H. Choi E. H. Lee Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet BioFactors 2006 26 273 281
5. C. C. Chuang K. Martinez G. Xie A. Kennedy A. Bumrunqpert A. Overman W. Jia M. K. Mclntosh Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-α-mediated inflammation and insulin resistance in primary human adipocytes Am. J. Clin. Nutr. 2010 92 1511 1521
6. S. S. Im J. W. Kim T. H. Kim X. L. Song S. Y. Kim H. I. Kim Y. H. Ahn Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter Exp. Mol. Med. 2005 37 101 110
7. C. L. Lee T. Y. Tsai J. J. Wang T. M. Pan In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia Appl. Microbiol. Biotechnol. 2006 70 533 540
8. C. L. Lee T. H. Kung C. L. Wu Y. W. Hsu T. M. Pan Monascin and ankaflavin act as novel hypolipidemic and high-density lipoprotein cholesterol-raising agents in red mold dioscorea J. Agric. Food Chem. 2010 58 9013 9019
9. T. Akihisa H. Tokuda K. Yasukawa M. Ukiya A. Kiyota N. Sakamoto T. Suzuki N. Tanabe H. Nishino Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects J. Agric. Food Chem. 2005 53 562 565
10. Y. C. Shi T. M. Pan Anti-diabetic effects of Monascus purpureus NTU 568 fermented products on streptozotocin-induced diabetic rats J. Agric. Food Chem. 2010 58 7634 7640
11. W. P. Chen B. Y. Ho C. L. Lee T. M. Pan Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet Int. J. Obes. 2008 32 1694 1704
12. P. C. Jou B. Y. Ho Y. W. Hsu T. M. Pan The effect of Monascus secondary polyketide metabolites, monascin and ankaflavin, on adipogenesis and lipolysis activity in 3T3-L1 J. Agric. Food Chem. 2010 58 12703 12709
13. J. Ohsumi S. Sakakibara J. Yamaguchi K. Miyadai S. Yoshioka T. Fujiwara H. Horikoshi N. Serizawa Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells Endocrinology 1994 135 2279 2282
14. D. Szalkowski S. White-Carrington J. Berger B. Zhang Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells Endocrinology 1995 136 1474 1481
15. K. S. Park T. P. Ciaraldi K. Lindgren L. Abrams-Carter S. Mudaliar S. E. Nikoulina S. R. Tufari J. H. Veerkamp A. Vidal-Puig R. R. Henry Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ J. Clin. Endocrinol. Metab. 1998 83 2830 2835
16. Y. H. Lai W. H. Hsu J. J. Huang S. C. Wu Antioxidant and anti-inflammatory effects of pigeon pea (Cajanus cajan L.) extracts on hydrogen peroxide and lipopolysaccharide-treated RAW264.7 macrophages Food Funct. 2012 3 1294 1301
17. B. H. Lee W. H. Hsu T. H. Liao T. M. Pan The Monascus metabolite monascin against TNF-α-induced insulin resistance via suppressing PPAR-γ phosphorylation in C2C12 myotubes Food Chem. Toxicol. 2011 49 2609 2617
18. T. Wada H. Kenmochi Y. Miyashita M. Sasaki M. Ojima M. Sasahara D. Koya H. Tsuneki T. Sasaoka Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet Endocrinology 2010 151 2040 2049
19. J. Diaz-Delfin M. Morales C. Caelles Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor-γ by inhibition of the c-Jun NH2-terminal kinase pathway Diabetes 2007 56 1865 1871
20. L. M. Leesnitzer D. J. Parks R. K. Bledsoe J. E. Cobb J. L. Collins T. G. Consler R. G. Davis E. A. Hull-Ryde J. M. Lenhard L. Patel K. D. Plunket J. L. Shenk J. B. Stimmel C. Therapontos T. M. Willson S. G. Blanchard Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662 Biochemistry 2002 41 6640 6650
21. I. Iankova R. K. Petersen J. S. Annicotte C. Chavey J. B. Hansen I. Kratchmaroval D. Sarruf M. Benkirane K. Kristiansen L. Faias Peroxisome proliferator-activated receptor-γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis Mol. Endocrinol. 2006 20 1494 1505
22. K. S. Park T. P. Ciaraldi K. Lindgren L. Abrams-Carter S. Mudaliar S. E. Nikoulina S. R. Tufari J. H. Veerkamp A. Vidal-Puig R. R. Henry Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ J. Clin. Endocrinol. Metab. 1998 83 2830 2835
23. H. S. Camp S. R. Tafuri T. Leff C-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma and negatively regulates its transcriptional activity Endocrinology 1999 140 392 397
24. C. Jiang A. T. Ting B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 1998 391 82 86
25. W. H. Hsu B. H. Lee T. H. Liao T. M. Pan Monascus-fermented metabolite monascin suppresses inflammation via PPARγ regulation and JNK inactivation in THP-1 monocytes Food Chem. Toxicol. 2012 50 1178 1186
26. P. Zimmet K. G. Alberti J. Shaw Global and societal implications of the diabetes epidemic Nature 2001 414 782 787
27. Y. Nagai Y. Nishio T. Nakamura H. Maegawa R. Kikkawa A. Kashiwagi Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha Am. J. Physiol.: Endocrinol. Metab. 2002 282 180 190
28. R. Nagata Y. Nishio O. Sekine Y. Nagai Y. Maeno S. Ugi H. Maegawa A. Kashiwagi Single nucleotide polymorphism (-468 Gly to Ala) at the promoter region of sterol regulatory element-binding protein-1c associates with genetic defect of fructose-induced hepatic lipogenesis J. Biol. Chem. 2004 279 29031 29042
29. M. J. Dekker Q. Su C. Baker A. C. Rutledge K. Adeli Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome Am. J. Physiol.: Endocrinol. Metab. 2010 299 685 694
30. S. H. Adams K. L. Stanhope R. W. Grant B. P. Cummings P. J. Havel Metabolic and endocrine profiles in response to systemic infusion of fructose and glucose in rhesus macaques Endocrinology 2008 149 3002 3008
31. M. B. Vos C. J. McClain Fructose takes a toll Hepatology 2009 50 1004 1006
32. D. Faeh K. Minehira J. M. Schwarz R. Periasamy S. Park L. Tappy Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men Diabetes 2005 54 1907 1913
33. K. Uyeda J. J. Repa Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis Cell Metab. 2006 4 107 110
34. K. Iizuka Y. Horikawa ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome Endocr. J. 2008 55 617 624
35. J. J. Repa G. Liang J. Ou Y. Bashmakov J. M. Lobaccaro I. Shimomura B. Shan M. S. Brown J. L. Goldstein D. J. Mangelsdorf Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ Genes Dev. 2000 14 2819 2830
36. J. Lin R. Yang P. T. Tarr P. H. Wu C. Handschin S. Li W. Yang L. Pei M. Uldry P. Tontonoz C. B. Newgard B. M. Spiegelman Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP Cell 2005 120 261 273
37. N. Roglans L. Vila M. Farre M. Alegret R. M. Sanchez M. Vazguez-Carrera J. C. Laguna Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats Hepatology 2007 45 778 788
38. T. Gebel M. Arand F. Oesch Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver FEBS Lett. 1992 309 37 40
39. C. C. Shih C. H. Lin W. L. Lin J. B. Wu Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats J. Ethnopharmacol. 2009 123 82 90
40. C. H. Wu S. M. Huang G. C. Yen Silymarin: a novel antioxidant with antiglycation and anti-inflammatory properties in vitro and in vivo Antioxid. Redox Signaling 2011 14 353 366
41. C. C. Lee W. H. Hsu S. R. Shen Y. H. Cheng S. C. Wu Fagopyrum tataricum (buckwheat) improved high-glucose-induced insulin resistance in mouse hepatocytes and diabetes in fructose-rich diet-induced mice Exp. Diabetes Res. 2012 2012 375673
42. A. S. Cheng Y. H. Cheng C. H. Chiou T. L. Chang Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells J. Agric. Food Chem. 2012 60 9180 9187
43. B. H. Lee W. H. Hsu Y. Y. Chang H. F. Kuo Y. W. Hsu T. M. Pan Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo Free Radical Biol. Med. 2012 53 2008 2016
44. J. H. Um S. J. Park H. Kang S. Yang M. Foretz M. W. McBurney M. K. Kim B. Viollet J. H. Chung AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 2010 59 554 564